GlassScriptPhysician profile
Edward N Shen
NPI 1609861822
$12,298.59
in general payments reported to CMS, 2019-2025
23 companies · $985 in 2025
The $985 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,105 · 2020: $1,485 · 2021: $1,775 · 2022: $1,445 · 2023: $1,445 · 2024: $1,058 · 2025: $985.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,469 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,468.70 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,560.27 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,580.88 | 2019-2025 | Jardiance |
| Boston Scientific Corporation | $1,453.96 | 2019-2024 | Rotablator Rotational Atherectomy System Console Kit, Synergy, Rhythmia Mapping System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $999.28 | 2019-2025 | Lifevest |
| Abiomed | $788.38 | 2019-2025 | Impella |
| Amarin Pharma, INC. | $682.77 | 2019-2022 | |
| Medtronic, INC. | $611.89 | 2021-2025 | Selectsecure, Aurora Ev-Icd Mri Surescan, Micra |
| Astrazeneca Pharmaceuticals LP | $527.51 | 2019-2024 | Farxiga, Brilinta |
| Shockwave Medical, INC | $480.53 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biotronik INC. | $465.38 | 2019-2023 | Pk Papyrus |
| Pfizer INC. | $399.51 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $387.73 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $353.04 | 2020-2024 | Camzyos, Eliquis |
| Impulse Dynamics (USA) INC. | $279.06 | 2024 | Optimizer |
| Janssen Pharmaceuticals, INC | $180.15 | 2020-2024 | Xarelto |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $163.12 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $127.58 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $86.01 | 2023-2024 | Verquvo |
| Teleflex LLC | $78.38 | 2025 | Turnpike |
| Lexicon Pharmaceuticals, INC. | $30.50 | 2023 | Inpefa |
| Baxter Healthcare | $25.63 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Novo Nordisk INC | $23.70 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $13.33 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Shen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.